Early efforts to use scDNA-seq in CLL research focused on evaluating SF3B1 mutations, which had long been assumed to be heterozygous in CLL (68), owing to their typical allelic burden of <50% (Figure 4). Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.